Int J Angiol 2020; 29(01): 039-044
DOI: 10.1055/s-0039-3401933
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Does Heart Valve Team Risk Assessment Predict Outcomes after Transcatheter Aortic Valve Replacement?

Michael A. Catalano
1   Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York
,
Bruce Rutkin
1   Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York
,
Nina Kohn
2   The Feinstein Institute for Medical Research, Manhasset, New York
,
Alan Hartman
1   Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York
,
Pey-Jen Yu
1   Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
09. Dezember 2019 (online)

Abstract

Consideration for transcatheter aortic valve replacement (TAVR) necessitates an integrated risk assessment by members of the Heart Valve Team. The utility of the integrated risk assessment for predicting TAVR outcomes is not established. This article aims to compare the utility of the integrated risk assessment to that of the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) score for predicting patient outcomes after TAVR. A total of 274 patients who underwent TAVR from January 2016 to August 2017 were included in this study. Patients were deemed intermediate or high risk by two surgeons on the Heart Valve Team based on an integrated risk assessment that incorporates the STS-PROM score, fragility measures, end-organ dysfunction, and surgeon evaluation. Patients were also deemed low, intermediate, or high risk based solely on their STS-PROM scores of <3%, ≥3% to <8%, and ≥8%, respectively. Differences in postoperative outcomes between intermediate- and high-risk groups as categorized by the integrated risk assessment versus STS-PROM were compared. There were no statistically significant differences in postoperative outcomes between patients who were deemed high and intermediate risk by the Heart Valve Team risk assessment. In contrast, postoperative complication rates were significantly higher in patients deemed high risk as compared with intermediate risk by STS-PROM. Integrated risk assessment by the Heart Valve Team is not superior to STS-PROM in predicting postoperative outcomes in patients undergoing TAVR.

 
  • References

  • 1 Nishimura RA, Otto CM, Bonow RO. , et al; American College of Cardiology; American College of Cardiology/American Heart Association; American Heart Association. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014; 148 (01) e1-e132
  • 2 Smith CR, Leon MB, Mack MJ. , et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364 (23) 2187-2198
  • 3 Arora S, Misenheimer JA, Jones W. , et al. Transcatheter versus surgical aortic valve replacement in intermediate risk patients: a meta-analysis. Cardiovasc Diagn Ther 2016; 6 (03) 241-249
  • 4 Leon MB, Smith CR, Mack MJ. , et al; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016; 374 (17) 1609-1620
  • 5 Thourani VH, Kodali S, Makkar RR. , et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 2016; 387 (10034): 2218-2225
  • 6 O'Brien SM, Shahian DM, Filardo G. , et al; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009; 88 (1, Suppl): S23-S42
  • 7 Shahian DM, O'Brien SM, Filardo G. , et al; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88 (1, Suppl): S43-S62
  • 8 Arnold SV, Reynolds MR, Lei Y. , et al; PARTNER Investigators. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation 2014; 129 (25) 2682-2690
  • 9 Asami M, Stortecky S, Praz F. , et al. Prognostic value of right ventricular dysfunction on clinical outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2019; 12 (04) 577-587
  • 10 Edwards FH, Cohen DJ, O'Brien SM. , et al; Steering Committee of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol 2016; 1 (01) 46-52
  • 11 Forcillo J, Condado JF, Ko YA. , et al. Assessment of commonly used frailty markers for high- and extreme-risk patients undergoing transcatheter aortic valve replacement. Ann Thorac Surg 2017; 104 (06) 1939-1946
  • 12 Green P, Arnold SV, Cohen DJ. , et al. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol 2015; 116 (02) 264-269
  • 13 Hioki H, Watanabe Y, Kozuma K. , et al; OCEAN-TAVI Investigators. Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2018; 92 (07) 1365-1373
  • 14 Schoenenberger AW, Moser A, Bertschi D. , et al. Improvement of risk prediction after transcatheter aortic valve replacement by combining frailty with conventional risk scores. JACC Cardiovasc Interv 2018; 11 (04) 395-403
  • 15 Greason KL, Eleid MF, Nkomo VT. , et al. Predictors of 1-year mortality after transcatheter aortic valve replacement. J Card Surg 2018; 33 (05) 243-249
  • 16 Hebeler KR, Baumgarten H, Squiers JJ. , et al. Albumin is predictive of 1-year mortality after transcatheter aortic valve replacement. Ann Thorac Surg 2018; 106 (05) 1302-1307
  • 17 Coylewright M, Mack MJ, Holmes Jr DR, O'Gara PT. A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis. J Am Coll Cardiol 2015; 65 (14) 1472-1480
  • 18 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44 (03) 837-845
  • 19 Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135 (01) 180-187
  • 20 Arsalan M, Weferling M, Hecker F. , et al. TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model. EuroIntervention 2018; 13 (13) 1520-1526
  • 21 Codner P, Malick W, Kouz R. , et al. Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model. EuroIntervention 2018; 14 (04) e405-e412
  • 22 Van Mieghem NM, Serruys PW. The art of risk stratification in TAVI. Eur Heart J 2013; 34 (25) 1859-1861
  • 23 Mylotte D, Martucci G, Piazza N. Patient selection for transcatheter aortic valve implantation: an interventional cardiology perspective. Ann Cardiothorac Surg 2012; 1 (02) 206-215
  • 24 Arnold SV, Afilalo J, Spertus JA. , et al; U.S. CoreValve Investigators. Prediction of poor outcome after transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 68 (17) 1868-1877
  • 25 Afilalo J, Lauck S, Kim DH. , et al. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol 2017; 70 (06) 689-700
  • 26 Hermiller Jr JB, Yakubov SJ, Reardon MJ. , et al; CoreValve United States Clinical Investigators. Predicting early and late mortality after transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 68 (04) 343-352
  • 27 Jain R, Duval S, Adabag S. How accurate is the eyeball test?: a comparison of physician's subjective assessment versus statistical methods in estimating mortality risk after cardiac surgery. Circ Cardiovasc Qual Outcomes 2014; 7 (01) 151-156
  • 28 Pons JM, Borras JM, Espinas JA, Moreno V, Cardona M, Granados A. Subjective versus statistical model assessment of mortality risk in open heart surgical procedures. Ann Thorac Surg 1999; 67 (03) 635-640